Australia markets open in 4 hours 58 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5421-0.0329 (-5.72%)
At close: 04:00PM EST
0.5400 -0.00 (-0.39%)
After hours: 06:33PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.5750
Open0.5850
Bid0.5421 x 900
Ask0.5470 x 900
Day's range0.5421 - 0.5897
52-week range0.5000 - 4.8000
Volume112,704
Avg. volume333,132
Market cap17.703M
Beta (5Y monthly)0.94
PE ratio (TTM)N/A
EPS (TTM)-0.2980
Earnings date09 Mar 2022 - 14 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

    SOLANA BEACH, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (G.I.) diseases, today announced that the Company will participate in the H.C. Wainwright BIOCONNECT Conference occurring virtually on January 10 – 13, 2022. Management’s presentation will be available on the conference website beginning at 7:00 a.m. ET on January 10, 2022. Investors participating in the conference who

  • GlobeNewswire

    Evoke Pharma Reports Third Quarter 2021 Financial Results

    SOLANA BEACH, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the quarter ended September 30, 2021 and recent corporate developments. “Through our hard work and valued partnership with Eversana, we continued to increase in-person access to physicians during the third quarter of 2021. We have also successfully executed on str

  • GlobeNewswire

    Evoke Pharma to Report Third Quarter 2021 Financial Results on November 10, 2021

    SOLANA BEACH, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its third quarter 2021 financial results on Wednesday, November 10, 2021, after the market closes. Evoke will host a conference call on Wednesday, November 10, 2021, at 4:30 p.m. ET to discuss the results. The dial-in numbers for the conference